+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diagnostic Substances Market - Global Forecast 2026-2032- Product Image
Diagnostic Substances Market - Global Forecast 2026-2032- Product Image
New

Diagnostic Substances Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015434
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The diagnostic substances market is a central pillar in healthcare and research, enabling accurate disease detection, customized patient care, and innovation across numerous clinical settings. Evolving technologies, shifting regulatory landscapes, and supply chain priorities continue to shape strategies for providers, manufacturers, and investors.

Market Snapshot: Diagnostic Substances Market Size and Growth

The Diagnostic Substances Market grew from USD 189.53 billion in 2025 to USD 201.40 billion in 2026, and is projected to expand at a CAGR of 6.70%, reaching USD 298.47 billion by 2032. This substantial trajectory is being driven by rapid molecular diagnostics advancements, higher throughput demands, and global investments in decentralized and laboratory-based healthcare environments.

Scope & Segmentation of the Diagnostic Substances Market

  • Product Types: Instruments (including analyzers, imaging equipment, molecular diagnostic platforms), kits and assays (ELISA, lateral flow, rapid test, targeted PCR kits), and reagents (antibody, antigen, enzyme, nucleic acid, recombinant proteins).
  • End-User Contexts: Diagnostic laboratories, forensic laboratories, hospitals and clinics, point-of-care settings, research and academic institutes.
  • Application Areas: Clinical diagnostics (targeting cardiology, endocrinology, infectious diseases, neurology, oncology), forensic investigations (focused on DNA, toxicology, blood testing), and research applications (drug discovery, genomics, proteomics).
  • Geographical Regions: Americas (with robust regulatory and reimbursement systems), Europe/Middle East/Africa (varying regulatory climates and infrastructure readiness), Asia-Pacific (investments in capacity, affordability priorities, regional reagent manufacturing).
  • Technologies: Next-generation sequencing, PCR platforms, ELISA, lateral flow devices, integrated software analytics, and decentralized rapid testing technologies.

Key Takeaways for Senior Decision-Makers

  • Diagnostics are critical for enabling proactive healthcare models, moving clinical practices from reaction to prevention, and helping to target therapy more precisely.
  • Integration of instruments, consumables, and service support is now a primary differentiator, promoting lifecycle value and robust vendor partnerships.
  • Adoption trends are influenced by complex regulatory, reimbursement, and quality assurance requirements, making early-stage compliance and evidence creation essential for vendor success.
  • Supply chain resilience, through diversified sourcing and regional manufacturing, reduces vulnerability and strengthens market positioning in dynamic environments.
  • Emergent data interoperability and analytics capabilities have become strategic assets; organizations translating diagnostic results into actionable insights gain both clinical and commercial influence.
  • Cross-regional adoption is shaped by local regulatory timelines, procurement practices, and the need for tailored market access strategies.

Tariff Impact: Responding to U.S. Trade Environment Shifts

The introduction of new U.S. tariffs in 2025 is reshaping procurement strategies for diagnostic substances. Senior decision-makers are prompted to consider nearshoring, regional sourcing, and enhanced supplier negotiations, embedding tariff risk into supplier selection and resource planning. Additionally, commercial contracts may emphasize tariff pass-through terms and supply risk allocation, while delayed investments and procurement cycles are emerging as companies reevaluate total cost of ownership. Operational strategies focus on transparency, scenario planning, redundancy in sourcing, local manufacturing, and regional collaborations to ensure reliable access to essential diagnostic products.

Methodology & Data Sources

Findings are grounded in a mixed-methods research framework, combining structured interviews with laboratory directors, procurement leaders, clinical specialists, and industry executives. This primary engagement is supported by technical consultations, peer-reviewed literature, regulatory documentation, and validated technical specifications. Triangulation and scenario analysis underpin the reliability and actionability of insights.

Diagnostic Substances Market: Why This Report Matters

  • Senior leaders will gain a strategic lens on evolving technology integration, regulatory dynamics, and procurement patterns informing investment and operational decisions.
  • The report delivers actionable intelligence for managing risk, optimizing supply strategies, and capitalizing on innovation-driven market opportunities in diagnostics.
  • Granular segmentation and cross-regional analysis support tailored strategies for product design, commercialization, and partnership formation, ensuring broad market applicability.

Conclusion

The diagnostic substances sector is essential to the advancement of healthcare delivery, research excellence, and operational efficiency. Senior decision-makers who align technical advancement with supply chain and commercialization strategies will be best positioned to drive sustainable value in an evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Diagnostic Substances Market, by Product Type
8.1. Instruments
8.1.1. Analyzers
8.1.2. Imaging Equipment
8.1.3. Molecular Diagnostic Instruments
8.1.3.1. Next-Generation Sequencing
8.1.3.2. PCR Machines
8.2. Kits & Assays
8.2.1. ELISA Kits
8.2.2. Lateral Flow Assays
8.2.3. PCR Kits
8.2.4. Rapid Test Kits
8.3. Reagents
8.3.1. Antibody Reagents
8.3.2. Antigen Reagents
8.3.3. Enzymes
8.3.4. Nucleic Acid Reagents
8.3.5. Recombinant Proteins
9. Diagnostic Substances Market, by End-User
9.1. Diagnostic Laboratories
9.2. Forensic Laboratories
9.3. Hospitals & Clinics
9.4. Point-of-Care Testing Facilities
9.5. Research & Academic Institutes
10. Diagnostic Substances Market, by Application
10.1. Clinical Diagnostics
10.1.1. Cardiology
10.1.2. Endocrinology
10.1.3. Infectious Diseases
10.1.4. Neurology
10.1.5. Oncology
10.2. Forensic
10.2.1. Blood Sample Testing
10.2.2. DNA Analysis
10.2.3. Toxicology
10.3. Research
10.3.1. Drug Discovery
10.3.2. Genomics Research
10.3.3. Proteomics Research
11. Diagnostic Substances Market, by Region
11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific
12. Diagnostic Substances Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Diagnostic Substances Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. United States Diagnostic Substances Market
15. China Diagnostic Substances Market
16. Competitive Landscape
16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. Abbott Laboratories
16.6. Agilent Technologies Inc.
16.7. Asuragen, Inc. by Bio-Techne Corporation
16.8. Becton, Dickinson and Company
16.9. Bio-Rad Laboratories Inc.
16.10. bioLytical Laboratories
16.11. bioMérieux SA
16.12. Cepheid by Danaher Corporation
16.13. DiaSorin S.p.A.
16.14. Enzo Biochem, Inc.
16.15. Hitachi Ltd.
16.16. Hoffmann-La Roche AG
16.17. Hologic Inc.
16.18. HyTest Ltd.
16.19. Illumina Inc.
16.20. Merck KGaA
16.21. OraSure Technologies, Inc.
16.22. Ortho Clinical Diagnostics
16.23. Qiagen N.V.
16.24. Quidel Corporation
16.25. Randox Laboratories Ltd.
16.26. Sekisui Diagnostics, LLC
16.27. Siemens AG
16.28. Sysmex Corporation by TOA Corporation
16.29. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DIAGNOSTIC SUBSTANCES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR MACHINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR MACHINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY LATERAL FLOW ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY LATERAL FLOW ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RAPID TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RAPID TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIBODY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIBODY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIBODY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIGEN REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIGEN REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIGEN REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NUCLEIC ACID REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NUCLEIC ACID REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NUCLEIC ACID REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY POINT-OF-CARE TESTING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY POINT-OF-CARE TESTING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY POINT-OF-CARE TESTING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENDOCRINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY BLOOD SAMPLE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY BLOOD SAMPLE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY BLOOD SAMPLE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DNA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DNA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DNA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY TOXICOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY TOXICOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY GENOMICS RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY GENOMICS RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY GENOMICS RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PROTEOMICS RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PROTEOMICS RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PROTEOMICS RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 165. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 169. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 171. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 172. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 175. EUROPE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 187. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 189. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 190. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 191. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 192. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 193. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 194. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 196. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 197. AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 213. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 214. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 215. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 216. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 217. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 219. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 220. ASEAN DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 221. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 223. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 224. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 225. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 226. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 227. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 228. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 230. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 231. GCC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 243. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 245. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 246. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 247. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 248. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 249. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 250. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 252. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 253. BRICS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 254. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 256. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 257. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 258. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 259. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 260. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 261. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 262. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 263. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 264. G7 DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 265. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 266. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 267. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 268. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 269. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 270. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 271. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 272. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 273. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 274. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 275. NATO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 288. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 289. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 290. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 291. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 292. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 293. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 294. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 295. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 296. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 297. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2032 (USD MILLION)
TABLE 298. CHINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Diagnostic Substances market report include:
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Asuragen, Inc. by Bio-Techne Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • bioLytical Laboratories
  • bioMérieux SA
  • Cepheid by Danaher Corporation
  • DiaSorin S.p.A.
  • Enzo Biochem, Inc.
  • Hitachi Ltd.
  • Hoffmann-La Roche AG
  • Hologic Inc.
  • HyTest Ltd.
  • Illumina Inc.
  • Merck KGaA
  • OraSure Technologies, Inc.
  • Ortho Clinical Diagnostics
  • Qiagen N.V.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics, LLC
  • Siemens AG
  • Sysmex Corporation by TOA Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 201.4 Billion
Forecasted Market Value ( USD ) by 2032 $ 298.47 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Diagnostic Substances - Industry Report - Product Image

Diagnostic Substances - Industry Report

  • Report
  • 161 Pages
  • Global
From
Oral Fluid Testing Market - Global Forecast 2026-2032 - Product Image

Oral Fluid Testing Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
RSV Diagnostics Market - Global Forecast 2026-2032 - Product Image

RSV Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Companion Diagnostics Market Report 2025 - Product Image

Companion Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Antimicrobial Resistance Diagnostics Market Report 2025 - Product Image

Antimicrobial Resistance Diagnostics Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Diagnostics Market

The Diagnostic Reagent market is a segment of the Diagnostics industry that focuses on the production and sale of reagents used in diagnostic tests. Diagnostic reagents are substances used to detect the presence of a particular disease or condition. They are used in a variety of medical tests, such as blood tests, urine tests, and tissue tests. Diagnostic reagents are typically produced in a laboratory setting and are used to detect the presence of a particular disease or condition. Diagnostic reagents are used in a variety of medical tests, such as blood tests, urine tests, and tissue tests. They are used to detect the presence of a particular disease or condition, and can be used to diagnose a variety of illnesses and conditions. Diagnostic reagents are typically produced in a laboratory setting and are used to detect the presence of a particular disease or condition. The Diagnostic Reagent market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.